Revium Rx (RVRC) Enterprise Value (2024 - 2026)

Revium Rx has disclosed Enterprise Value across 3 years of filings, most recently posting $99.9 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 229.04% year-over-year to $99.9 million; the TTM figure through Jun 2026 stood at $99.9 million (up 229.04% YoY), while the FY2025 annual figure was $28.9 million, up 45.93% from the prior year.
• Enterprise Value came in at $99.9 million for Q2 2026 at Revium Rx, up from $28.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $99.9 million in Q2 2026 to a low of $19.8 million in Q4 2024.
• Average Enterprise Value over 3 years is $44.7 million, with a median of $29.6 million recorded in 2025.
• Year-over-year, Enterprise Value soared 45.93% in 2025 and surged 229.04% in 2026.
• Over 3 years, Enterprise Value stood at $19.8 million in 2024, then soared by 45.93% to $28.9 million in 2025, then jumped by 246.1% to $99.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $99.9 million in Q2 2026, $28.9 million in Q4 2025, and $30.4 million in Q2 2025.